Congenital Hearing L… · 02:57 07 May 2024
hereditary clotting disorder :: Article CreatorImpact Of Recombinant Replacement Therapy Detailed In Genetic Clotting Disorder A recombinant replacement for the… Read More
Adzynma Blog Posts
Personalized Content… · 18:23 10 Nov 2023
The US Food and Drug Administration (FDA) has approved Takeda Pharmaceuticals’ Adzynma, the first recombinant protein product for prophylactic (preventive) or on‑demand enzyme re… Read More
Health Is Cure · 13:02 10 Nov 2023
The FDA approved a recombinant ADAMTS13 protein product (Adzynma) as a prophylactic or on-demand enzyme replacement therapy for patients with congenital thrombotic thrombocytopenic purpura… Read More